GCM
PRCT icon

Graham Capital Management’s Procept Biorobotics PRCT Stock Holding History

Graham Capital Management’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,779
Closed -$218K – 1562
2025
Q2 		$218K Sell
3,779
-32,455
-90% -$1.83M ﹤0.01% 1100
2025
Q1 		$2.11M Buy
36,234
+33,379
+1,169% +$2.28M 0.04% 313
2024
Q4 		$230K Buy
+2,855
New +$244K ﹤0.01% 1033
2023
Q1 		– Sell
-13,925
Closed -$578K – 1277
2022
Q4 		$578K Buy
+13,925
New +$598K 0.02% 720

Other funds holding PRCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Graham Capital Management's PRCT Position: Q3 2025 in Review

Graham Capital Management sold out of Procept Biorobotics (PRCT) in Q3 2025, closing a stake of 3,779 shares — an estimated $218K sold.

Graham Capital Management first reported a position in PRCT in Q4 2022 and held it in 4 quarters. The position peaked at $2.11M in Q1 2025. 242 funds tracked by Wall St. Rank hold PRCT as of Q3 2025.

  • Graham Capital Management reported no remaining Procept Biorobotics position as of Q3 2025 after selling out during the quarter.
  • Graham Capital Management sold 3,779 Procept Biorobotics shares in Q3 2025, an estimated $218K.
  • Graham Capital Management first reported a position in Procept Biorobotics in Q4 2022 and held it in 4 quarters.
  • Graham Capital Management's Procept Biorobotics position peaked at $2.11M in Q1 2025.
  • 242 funds tracked by Wall St. Rank held Procept Biorobotics as of Q3 2025.

Based on Graham Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.